comparemela.com

Latest Breaking News On - Neuron access system - Page 1 : comparemela.com

Penumbra (NYSE:PEN) Upgraded by Zacks Investment Research to Hold

Penumbra (NYSE:PEN – Get Rating) was upgraded by Zacks Investment Research from a “strong sell” rating to a “hold” rating in a research note issued on Wednesday, Zacks.com reports. According to Zacks, “Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company’s portfolio of products primarily addresses neuro […]

Penumbra (NYSE:PEN) Downgraded by Zacks Investment Research

Penumbra (NYSE:PEN – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “strong sell” rating in a note issued to investors on Wednesday, Zacks.com reports. According to Zacks, “Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company’s portfolio of products primarily addresses […]

Penumbra (NYSE:PEN) Stock Rating Lowered by Zacks Investment Research

Penumbra (NYSE:PEN – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Friday, Zacks.com reports. According to Zacks, “Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company’s portfolio of products […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.